Major Rating Factors:
Fair overall results on stability tests (4.4 on a scale of 0 to 10) including negative cash flow from operations for 2022. Weak profitability (1.3) with operating losses during 2022. Return on equity has been low, averaging -81.0%. Strong capitalization (10.0) based on excellent risk adjusted capital (severe loss scenario). Capital levels have been relatively consistent over the last five years.
Other Rating Factors:
High quality investment portfolio (9.2). Excellent Liquidity (7.0).
Stability Factors:
D - Limited diversification of general business, policy, and/or investment risk.
F - Negative cash flow.
G - Fast asset or premium growth.
T - Significant trends in critical asset, liability, income or expense items.
Principal Lines of Business:
Ind health (99.5%), other (0.5%)
Licensed in:
All states except NY, PR